­Mahesh Seetharam

1.5k citations
62 papers · 922 indexed · 1 hit paper · h-index 15

­Mahesh Seetharam

56 papers receiving 916 citations

Hit Papers

Pan-cancer efficacy of pralsetinib in patients with RET f...14420222026202320244080120

Peers

­Mahesh Seetharam
Comparison fields: 5 of 72
  • Hematology 261
  • Oncology 408
  • Genetics 125
  • Pulmonary and Respiratory Medicine 286
  • Cancer Research 122
Replace Su S. Chen with:
Su S. Chen United States
José María Sayagués Spain
TuDung T. Nguyen United States
Eric Raefsky United States
Han Myint United States
Gabriella Sammarelli Italy
José C. Cruz United States
José R. Valbuena United States
C. Faul Germany
Paola Casieri Italy
­Mahesh Seetharam relative to Su S. Chen United States Su S. Chen's profile →
Citations per field
00.5×4.1×
Su S. Chen · 1×
Citations per year

Countries citing papers authored by ­Mahesh Seetharam

Since Specialization
Citations

This map shows the geographic impact of ­Mahesh Seetharam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by ­Mahesh Seetharam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites ­Mahesh Seetharam more than expected).

Fields of papers citing papers by ­Mahesh Seetharam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by ­Mahesh Seetharam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by ­Mahesh Seetharam. The network helps show where ­Mahesh Seetharam may publish in the future.

Co-authorship network

The 25 scholars most cited alongside ­Mahesh Seetharam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with ­Mahesh Seetharam Line = papers co-authored together ­Mahesh Seetharam links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20253
3 20243
4 20241
5 20241
6 20245
7 20241
8 20232
9 20234
10 20221
11 20228
12 20220
13 20217
14 20203
15 202023
16 20201
17 201974
18 20157
19 2009113
20 200756

About ­Mahesh Seetharam

­Mahesh Seetharam is a scholar working on Oncology, Hematology and Pulmonary and Respiratory Medicine, having authored 62 papers that have together received 922 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (21 papers), Vascular Tumors and Angiosarcomas (9 papers), Acute Myeloid Leukemia Research (9 papers), CAR-T cell therapy research (8 papers), Lymphoma Diagnosis and Treatment (8 papers), Cancer Genomics and Diagnostics (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Cardiac tumors and thrombi (5 papers). The work is most often cited by research in Hematology (261 citations), Oncology (408 citations) and Genetics (125 citations) ­Mahesh Seetharam has collaborated with scholars based in United States, Spain and Germany. Frequent co-authors include Megan Meyer, Daniel A. Arber, Olga K. Weinberg, Li Ren, Jason Gotlib, Lisa Ma, Katie Seo, James L. Zehnder, Jason D. Merker and Ash A. Alizadeh. Their work appears in journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026